Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

ClinicalTrials.gov ID: NCT04625725

Public ClinicalTrials.gov record NCT04625725. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 12:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety and efficacy of a single dose of AZD7442(× 2 IM injections) compared to placebo for the prevention of COVID-19.

Study identification

NCT ID
NCT04625725
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
5,197 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 20, 2020
Primary completion
Aug 15, 2022
Completion
Dec 7, 2023
Last update posted
Dec 30, 2024

2020 – 2023

United States locations

U.S. sites
60
U.S. states
26
U.S. cities
56
Facility City State ZIP Site status
Research Site Birmingham Alabama 35215
Research Site Tempe Arizona 85284
Research Site Little Rock Arkansas 72205
Research Site Cerritos California 90703
Research Site Fresno California 93720
Research Site Garden Grove California 92844
Research Site Huntington Beach California 92647
Research Site Lancaster California 93534
Research Site Modesto California 95350
Research Site Victorville California 92394
Research Site Westminster California 92683
Research Site Hartford Connecticut 06112
Research Site Middlebury Connecticut 06762
Research Site Clearwater Florida 33756
Research Site Coral Springs Florida 33071
Research Site Hollywood Florida 33024
Research Site Lauderdale Lakes Florida 33313
Research Site Miami Florida 33125
Research Site Ormond Beach Florida 32174
Research Site Pompano Beach Florida 33064
Research Site Wesley Chapel Florida 33545
Research Site West Palm Beach Florida 33409
Research Site Atlanta Georgia 30328
Research Site Columbus Georgia 31904
Research Site Conyers Georgia 30094
Research Site Marietta Georgia 30060
Research Site Honolulu Hawaii 96859
Research Site Chicago Illinois 60607
Research Site Hazel Crest Illinois 60429
Research Site Quincy Illinois 62301
Research Site Evansville Indiana 47714
Research Site Noblesville Indiana 46060
Research Site Wichita Kansas 67205
Research Site Wichita Kansas 67214
Research Site Minneapolis Minnesota 55404
Research Site Minneapolis Minnesota 55435
Research Site St Louis Missouri 63141
Research Site Omaha Nebraska 68134
Research Site Las Vegas Nevada 89128
Research Site Albuquerque New Mexico 87109
Research Site Jamaica New York 11432
Research Site Ridgewood New York 11385
Research Site The Bronx New York 10461
Research Site Greensboro North Carolina 27410
Research Site Columbus Ohio 43213
Research Site Oklahoma City Oklahoma 73104
Research Site Summerville South Carolina 29485
Research Site Rapid City South Dakota 57701
Research Site Austin Texas 78751
Research Site El Paso Texas 79925
Research Site El Paso Texas 79935
Research Site Houston Texas 77054
Research Site San Antonio Texas 78215
Research Site San Antonio Texas 78251
Research Site Shenandoah Texas 77384
Research Site Sugar Land Texas 77479
Research Site Layton Utah 84041
Research Site Alexandria Virginia 22304
Research Site Chesapeake Virginia 23320
Research Site Tacoma Washington 98402

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04625725, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 30, 2024 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04625725 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →